Merck's fall from grace

Article Abstract:

Merck & Co., the world's largest drug maker, known for making the first medicines for cholesterol, osteoporosis and high blood pressure is facing a downslide. The firm was faced with a combination of problems ranging from fall in sales of its best selling medicine, losing patent exclusivity, company's policy for cheaper generic competition and inability to make better products to replace new ones along with weak leadership.

Merck & Company Inc.

Getting together on genomics

Article Abstract:

The lessons learnt by the pharmaceutical company Wyeth while working with the US and European regulatory agencies to mine their pharmacogenomic data are revealed. The data were a part of Wyeth's efforts to lay groundwork for regularly integrating genomics data into future clinical trials, before the US Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) issued the new guidelines.

Legal issues & crime, Government regulation (cont), General services, Government regulation, Contracts & orders received, Legal/Government Regulation, Contracts & orders let, Science, Space & Tech-Total Govt, Space Research and Technology, Laws, regulations and rules, Contracts, Company systems management, Information management, Contract agreement, Wyeth, Scientific bureaus, Science agencies, WYE

Daniel Skovronsky: a physician-scientist and business leader

Article Abstract:

Daniel Skovronsky is a well-known physician scientist and business leader, who has contributed mainly in developing new treatments for people suffering from the Alzheimer's disease.

Science & research, Research, Medical scientists, Skovronsky, Daniel